Patients should report persistent injection site changes, unexplained neck masses, severe gastrointestinal symptoms, or signs of pancreatitis promptly for appropriate clinical assessment and management
No identifiable subgroup had a distinctly lower risk of stopping semaglutide. Researchers identified 77,310 adults who started using semaglutide from nationwide health registries in Denmark (median age, 50 years
Patients and healthcare providers can stay informed about Semaglutide and lupus management by accessing reputable sources of information, including peer-reviewed journals, clinical practice guidelines, patient advocacy organizations, and regulatory agencies
Semaglutide can be a helpful tool, but it should be used in conjunction with a comprehensive weight loss plan
Your provider adjusts based on your response